Company intelligence / Profile preview

Symbio Generrics

Bengaluru, Bangalore/Karnataka, Indiasymbiogenerics.com ↗

Ownership: Private
Employees: ~91
Development stage: Commercial

Overview

Symbio Generrics is a commercial-stage company specializing in the manufacture and global supply of generic active pharmaceutical ingredients and intermediates. The company has established itself as a key supplier to both emerging and regulated markets with GMP-certified facilities near Bengaluru and Visakhapatnam. It offers contract development services for advanced intermediates/APIs but does not conduct clinical trials or develop proprietary new chemical entities.

Therapeutic areas: PulmonologyEndocrinologyImmunologyGastroenterologyCardiovascularNeurology
Modalities: Small moleculeEnzyme
Industry: Contract Manufacturing Organization

Partnerships

Works with global pharma companies as CDMO/API supplier

Beyond the preview

Go deeper on Symbio Generrics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symbio Generrics.

Explore the full profile